Toyobo Co., Ltd. · TSE:3101
Toyobo — Q3 FY3/2022 Earnings Presentation
20 slides from Toyobo's earnings presentation, Feb 10, 2022
Slide 1: Presentation to Investors for the Third Quarter Ended December 31, 2021
February 10, 2022 Presentation to Investors for the Third Quarter Ended December 31, 2021 TOYOBO CO., LTD.
Slide 2: Highlights
Highlights Q3 FY 3/22 Results - Despite the impact of rising raw material and fuel prices, sales and profit increased as industrial films and reagents for PCR testing performed strongly. - Operating profit of ¥22.9 bn. (1.3-fold), and profit of ¥12.1 bn. Profit attributable to Net sales Operating pr
Slide 3: Summary of Results: P&L
Summary of Results: P&L (¥bn.) Q3 FY 3/21 Q3 FY 3/22 YOY (cumulative) (cumulative) Amount % Net sales 243.9 274.5 + 30.7 +12.6% Operating profit 18.3 22.9 + 4.6 + 25.1% (Ratio to sales) 7.5% 8.3% - - Ordinary profit 12.5 18.2 + 5.7 + 46.0% Extraordinary income and losses -12.7 -3.2 - - Profit attrib
Slide 4: Analysis in Changes in Operating Profit
Analysis in Changes in Operating Profit Volume Others 25.0 +11.3 -1.3 Raw materials and fuel costs Prices 20.0 -8.7 +3.3 15.0 (¥bn.) 22.9 10.0 18.3 - Industrial film (＋4.6 ) - PCR-related products 5.0 - Depreciation - Safety and disaster prevention measure expenses 0.0 Q3 FY 3/21 Q3 FY 3/22 (cumulat
Slide 5: Summary of Results: BS
Summary of Results: BS (B) (A) (¥bn.) Mar. 31, 2020 Mar. 31, 2021 Dec. 31, 2021 (A) - (B) Total assets 488.9 491.2 510.5 + 19.3 Cash and deposits 25.2 34.7 20.9 - 13.8 Inventories 80.6 76.3 95.0 + 18.7 Property, plant and equipment 231.5 224.6 231.9 + 7.3 Net assets 182.6 188.6 202.4 + 13.7 Sharehol
Slide 6: Summary of Results: Segment
Summary of Results: Segment (¥bn.) Net sales Operating profit Q3 FY 3/21 Q3 FY 3/22 Q3 FY 3/21 Q3 FY 3/22 YOY (cumulative) (cumulative) (cumulative) (cumulative) Films and Functional 113.0 127.3 14.3 16.6 + 2.2 Materials Mobility 25.5 32.2 - 1.7 - 1.4 + 0.2 Lifestyle and Environment 77.3 82.4 3.0 2.
Slide 7: Films and Functional Materials
Films and Functional Materials (¥bn.) FY 3/21 FY 3/22 Q3 cumulative YOY Q3 Q3 H1 Q3 H1 Q3 Amount % (cumulative) (cumulative) Net sales 73.8 39.2 113.0 85.9 41.4 127.3 + 14.3 +12.6% Operating profit 8.7 5.6 14.3 12.2 4.3 16.6 + 2.2 +15.6% (OPM) 11.8% 14.3% 12.7% 14.2% 10.5% 13.0% ‐ ‐ Packaging film -
Slide 8: Mobility
Mobility (¥bn.) FY 3/21 FY 3/22 Q3 cumulative YOY Q3 Q3 H1 Q3 (cumulative) H1 Q3 (cumulative) Amount % Net sales 15.0 10.5 25.5 21.6 10.6 32.2 + 6.6 +26.0% Operating profit - 1.3 - 0.4 - 1.7 - 0.9 - 0.6 - 1.4 + 0.2 ‐ (OPM) - - - - - - ‐ ‐ Segment overall: Affected by the rise of raw material prices
Slide 9: Lifestyle and Environment
Lifestyle and Environment (¥bn.) FY 3/21 FY 3/22 Q3 cumulative YOY Q3 Q3 H1 Q3 H1 Q3 Amount % (cumulative) (cumulative) Net sales 50.2 27.1 77.3 54.7 27.7 82.4 + 5.1 + 6.6% Operating profit 1.8 1.2 3.0 1.9 0.8 2.7 - 0.3 - 11.5% (OPM) 3.5% 4.6% 3.9% 3.4% 2.9% 3.2% ‐ ‐ Environmental solutions - Volati
Slide 10: Concentrate resources for the textile business
Concentrate resources for the textile business Establish TOYOBO Textiles Co., Ltd. (April 1, 2022) - Separate textile business from TOYOBO STC CO., LTD., integrate with TOYOBO UNI PRODUCTS CO., LTD. - Newly establish TOYOBO TEXTILE CO., LTD. through this integration - TOYO KNIT CO., LTD. will become
Slide 11: Life Science
Life Science (¥bn.) FY 3/21 FY 3/22 Q3 cumulative YOY Q3 Q3 H1 Q3 (cumulative) H1 Q3 (cumulative) Amount % Net sales 12.4 6.9 19.2 16.3 8.2 24.6 + 5.3 + 27.8% Operating profit 1.6 1.6 3.2 4.6 1.8 6.4 + 3.2 + 102.2% (OPM) 12.9% 22.7% 16.4% 28.2% 21.6% 26.0% ‐ ‐ Biotechnology - Sales of raw materials
Slide 12: Topics: For Becoming Carbon Neutral
Topics: For Becoming Carbon Neutral Renovate in-house thermal power station at Iwakuni Production Center - Transition from coal to liquid natural gas and RPF* for fuel ＊RPF: Solid fuel, the main raw material of which is waste paper and waste plastics - Reduce GHG emissions by 80,000 tons per year
Slide 13: Forecasts for FY 3/22
Forecasts for FY 3/22 Forecasts of operating profit of ¥29.0 bn., net profit of ¥13.0 bn. remain unchanged since industrial films, reagents for PCR testing, etc. performed strongly despite concerns regarding delays in revising sales prices, and the spread of COVID-19 variants. (¥bn.) FY 3/21 FY 3/22
Slide 14: Analysis in Changes in Operating Profit
Analysis in Changes in Operating Profit 35.0 Volume Others Raw materials +11.1 -2.5 30.0 and fuel costs Prices -10.6 +4.4 25.0 20.0 (¥bn.) 15.0 29.0 - Industrial film 26.7 - PCR-related products ( ＋2.3 ) 10.0 - Depreciation - Safety and disaster prevention 5.0 measure expenses 0.0 FY 3/21 FY 3/22 Pr
Slide 15: Forecasts by Segment
Forecasts by Segment (¥bn.) Net sales Operating profit FY 3/21 FY 3/22 FY 3/21 FY 3/22 Previous YOY forecasts result forecasts result forecasts (Nov. 2021) Films and 152.8 170.0 20.0 21.0 + 1.0 21.0 Functional Materials Mobility 36.6 43.0 - 1.6 - 1.8 - 0.2 - 1.4 Lifestyle and Environment 109.1 112.0
Slide 16: Appendix
Appendix
Slide 17: Business performance
Business performance (¥bn.) FY 3/21 FY 3/22 Net sales Q3 Q3 Q1 Q2 Q3 (cumulative) full year Q1 Q2 Q3 (cumulative) Films and Funcitonal Materials 36.3 37.5 39.2 113.0 152.8 45.7 40.2 41.4 127.3 Mobility 6.8 8.2 10.5 25.5 36.6 11.1 10.5 10.6 32.2 Lifestyle and Environment 22.9 27.3 27.1 77.3 109.1 27.
Slide 18: Topics
Topics Issued social bonds - Issued ¥10.0 bn. in December 2021 - Appropriate for expenses associated with manufacture of medical membranes and expenses associated with manufacture of reagents Received prize for excellence for the first time at “2021 Internet IR Awards” - Daiwa Investor Relations
Slide 19: Please Note
Please Note The business performance forecasts and targets included in the business plans contained in this presentation are based on information known to the Company’s management as of the day of presentation. Please be aware that the content of the future forecasts may differ significantly from ac
Slide 20: All Rights Reserved
All Rights Reserved